CGT9486 plus sunitinib
CGT9486-21-301
Phase 3 small_molecule active
Quick answer
CGT9486 plus sunitinib for Advanced Gastrointestinal Stromal Tumors is a Phase 3 program (small_molecule) at Cogent Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cogent Biosciences
- Indication
- Advanced Gastrointestinal Stromal Tumors
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active